CA
NZ
UK
AU
IND
US
Redwood Trust, Inc. filed its Form 10-Q for the quarterly period ended September 30, 2026 with the Securities and Exchange Commission on November 9, 2026, reporting a net loss of $45.5 million for the third quarter and total assets of approximately $30.4 billion.
Clearway Energy, Inc. filed its quarterly report on Form 10-Q with the SEC on November 9, 2026, covering the period ended September 30, 2026, and disclosing share counts, debt structure, and a completed solar portfolio acquisition.
MARA Holdings, Inc. filed its Form 10-Q for the quarterly period ended September 30, 2026, with the SEC on November 9, 2026, reporting a net income of $632.071 million for the third quarter alongside a net loss of $1.241643 billion for the nine months …
Occidental Petroleum Corporation filed its Form 10-Q for the quarterly period ended September 30, 2026 with the U.S. Securities and Exchange Commission on November 9, 2026, reporting continued operations following the January 2026 close of its OxyChem divestiture.
Attovia Therapeutics, Inc. filed a Form 8-K on November 9, 2026, disclosing positive topline 12-week results from its Phase 1b study of ATTO-1310 in patients with chronic pruritus and high-itch atopic dermatitis, alongside a report of its third-quarter 2026 financial results.
Myomo, Inc. filed its quarterly report on Form 10-Q with the SEC on November 9, 2026, covering the three and nine months ended September 30, 2026, disclosing revenue growth alongside a widening accumulated deficit and reduced cash position.
Rocket Lab Corporation filed its quarterly report on Form 10-Q with the U.S. Securities and Exchange Commission on November 9, 2026, covering the fiscal quarter ended September 30, 2026.
Ethan Allen Interiors Inc. filed its Form 10-Q for the quarterly period ended September 30, 2026, reporting first-quarter fiscal 2027 results that included a year-over-year decline in net sales and net income, alongside a $92.2 million cash dividend payment.
Bank7 Corp. filed its quarterly report on Form 10-Q for the period ended September 30, 2026, with the SEC on November 9, 2026, disclosing financial results for the third quarter and first nine months of fiscal 2026.
GeneDx Holdings Corp. filed its Form 10-Q for the quarterly period ended September 30, 2026, with the SEC on November 9, 2026, reporting condensed consolidated financial statements and management discussion for the third quarter.
Please wait processing your request...